Validation of PREDICT Version 2.2 in a Retrospective Cohort of Indian Women With Operable Breast Cancer.

Nita S NairBhavika KothariSudeep GuptaSadhana KanannVaibhav VanmaliRohini W HawaldarAshutosh TondareShabina SiddiqueVani Parmar Shalaka Joshi Rajendra Achyut Badwe

Published in: JCO global oncology (2023)

PREDICT version 2.2 overestimated the number of deaths, with lower predicted 5-year OS compared with the observed value, in this retrospective Indian cohort. The reasons for this discrepancy could be differing biologic characteristics and possible selection bias in our cohort. We recommend a prospective validation of PREDICT in Indian patients and advocate caution in its use until such validation is achieved.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
rheumatoid arthritis
psychometric properties
prognostic factors
peritoneal dialysis
cross sectional
young adults
patient reported